2ⁿᵈ Edition of the Cancer R&D World Conference 2026

Abstract

Artificial intelligence is redefining the oncology landscape by transforming imaging data into actionable clinical intelligence that enhances immuno oncology treatment strategies. As immunotherapies and antibody based treatments become increasingly complex, the ability to integrate radiologic, molecular, and clinical data into structured decision frameworks is essential for optimizing patient outcomes. This presentation explores how AI driven imaging analytics can strengthen clinical decision support systems across the cancer care continuum.

Advanced machine learning algorithms applied to radiographic imaging enable early detection of tumor response patterns, identification of immune related adverse events, and differentiation between true progression and pseudoprogression in patients receiving immunotherapy. When combined with biomarker data and longitudinal clinical datasets, imaging intelligence supports real time treatment adaptation and patient stratification. A critical enabler of reliable AI deployment in oncology is high quality, standardized clinical data infrastructure. Structured data governance models, validated data capture systems, and harmonized oncology endpoints ensure that imaging derived insights are reproducible, regulatory compliant, and clinically meaningful.

This session highlights frameworks for integrating imaging analytics within broader clinical data ecosystems to support transparent model validation, audit readiness, and regulatory confidence. Case driven examples demonstrate how AI powered imaging platforms can reduce diagnostic variability, accelerate response assessment, and enhance multidisciplinary tumor board decision making. By aligning imaging innovation with robust clinical data strategy, oncology programs can translate computational insights into practical, evidence based treatment pathways.

This presentation provides a roadmap for integrating artificial intelligence, advanced imaging, and structured clinical data systems to strengthen decision support in immuno oncology, ultimately advancing precision cancer care and improving patient survival outcomes